|
[Related PubMed/MEDLINE]
Total Number of Papers: 16
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: Scl GVHD |
| Long Form |
: sclerodermatous graft-vs-host disease |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
The Gut Bacteria Dysbiosis Contributes to Chronic Graft-Versus-Host Disease Associated With a Treg/Th1 Ratio Imbalance. |
IFN-gamma, IL |
| 2 |
2020 |
CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model. |
cGVHD, hMSC, hMSCs |
| 3 |
2020 |
Fractional CO2 laser for the treatment of sclerodermatous cGVHD. |
--- |
| 4 |
2017 |
A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice. |
alpha-SMA, IL, SSc, TGF, TNF |
| 5 |
2017 |
Mesenchymal Stem Cells (MSCs) AttenuateCutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model. |
GVHD, MSCs |
| 6 |
2017 |
Stretching Reduces Skin Thickness and Improves Subcutaneous Tissue Mobility in a Murine Model of Systemic Sclerosis. |
SSc |
| 7 |
2016 |
IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease. |
dLNs, LECs, S1P, SSc |
| 8 |
2014 |
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages. |
LXRs, Tsk-1 |
| 9 |
2013 |
What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis? |
IFN, SSc |
| 10 |
2012 |
Egr-ly awaiting a "personalized medicine" approach to treat scleroderma. |
Egr, IL-13 |
| 11 |
2012 |
Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets. |
--- |
| 12 |
2008 |
Animal models in systemic sclerosis. |
SSc |
| 13 |
2006 |
Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. |
mRNAs, VEGF |
| 14 |
2003 |
Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. |
LAP, TGF-beta1 |
| 15 |
2002 |
Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. |
--- |
| 16 |
1999 |
Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. |
--- |
|
A Search Service for Abbreviation / Long Form
